Fig. 1From: HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancerThe transcriptional expression of SMARCAs in different types of cancers (ONCOMINE database). The differences of transcription levels were compared by students’ t test. The threshold was restricted as follows: P value: 0.01, fold change: 2, gene rank: 10%, data type: mRNABack to article page